Active substanceLidocaine + ChlorhexidineLidocaine + Chlorhexidine
Similar drugsTo uncover
  • Instillagel®
    gel locally 
    Farco-Pharma GmbH     Germany
  • Lidocaine cage
    gel locally 
  • Lidocaine Asept
    spray locally 
    BIOGEN NPC, OAO     Russia
  • Dosage form: & nbspgel for topical application
    Composition:

    100 ml of gel contain: Active substances: lidocaine hydrochloride - 2 g, chlorhexidine gluconate - 0.05 g

    Excipients: methyl 4-hydroxybenzoate, propyl-4-hydroxybenzoate, propylene glycol, hydroxyethylcellulose, purified water q.s

    Description:Practically colorless, transparent, viscous, homogeneous gel.
    Pharmacotherapeutic group:antiseptic + local anesthetic
    ATX: & nbsp

    N.01.B.B.52   Lidocaine in combination with other drugs

    Pharmacodynamics:

    Combined drug, which has antiseptic and local anesthetic effect. Chlorhexidine - antimicrobial drug, acting on gram-positive and gram-negative microorganisms, yeast, dermatophytes. Effective against causative agents of sexually transmitted infections - chlamydia, ureaplasmosis, gardnerellez, trichomoniasis, gonorrhea, syphilis, genital herpes. Keeps activity (although somewhat reduced) in the presence of blood, pus, various secrets and organic substances.

    Lidocaine is a local anesthetic.

    Antimicrobial action and adequate anesthesia develops in 5-10 minutes. after application of the drug.

    The water-soluble clear gel provides a clear optical view for various endoscopic procedures.

    Indications:In urology: prevention of infectious complications, for lubrication and anesthesia: catheterization of the urethra, introduction and replacement of a permanent catheter, urethroscopy and cystoscopy, urethral bougie, surgical interventions on the urethra and bladder, transurethral prostatectomy, dysuria and cystalgia treatment, nephrostome manipulation, urodynamic examination, local therapy of non-nasal urethritis.

    In obstetrics and gynecology: prevention of infectious complications, for lubrication and anesthesia: with prenatal sanation of the cervix and vagina, diagnostic scraping of the walls of the cervical canal and uterine cavity, introduction and removal of intrauterine contraceptives (IUDs), hysteroscopy, cervical biopsy, endometrial biopsy, cervical polypectomy during surgery transvaginal access, and formal abortion.In the combination therapy of bacterial cervicitis, nonspecific colpitis, chronic endometritis.

    In abdominal surgery and proctology: prevention of infectious complications, for lubrication and anesthesia: for all types of endoscopic examinations, for operative and diagnostic interventions in proctology, for protection from damage to the rectum and large intestine during endoscopic manipulation, when replacing fistula catheters and drains, and care for entoroastomas.

    And: Used as a lubricant, disinfectant and topical anesthetic for intubation and mechanical ventilation (IVL), pediatric practice.

    Contraindications:

    Hypersensitivity to the drug and alkyl-4-hydroxybenzoates (parabens); pronounced bradycardia (possibly oppression of the cardiovascular system).

    Carefully:

    Pregnancy (1 trimester).

    Dosing and Administration:

    A tip and a syringe with gel (6 or 11 ml of the drug) are removed from the package. Then, the protective cap is removed from the cannula of the syringe and the cannula of the syringe is inserted tightly into the socket of the tip.By uniform pressure on the syringe plunger, fill the tube of the installation tip completely over the entire length of the tube.

    In urological diseases, men use a syringe with 11 ml of gel: in the area of ​​the external opening of the urethra (after the treatment of the glans penis with a disinfectant solution) several drops of gel are applied by pressing the syringe onto the piston, then the cannula of the syringe is inserted into the opening of the urethra through the applied gel and slowly 11 ml of gel is injected into the urethra. The head of the penis in the area of ​​the coronary sulcus is short-circuited to prevent backflow of the gel. When carrying out cystoscopy, you should completely cover the urethra with the gel, including the external sphincter. To do this, you must enter into the urethra 11 ml of the drug, and if necessary, another 6-11 ml of the drug. Women use a syringe with 6 ml of gel. On the area surrounding the external aperture of the urethra, several drops of gel are applied (after treatment with the disinfectant solution) and the cannula of the syringe is inserted into the opening of the urethra through the applied gel.Then, the contents of the syringe in the amount of about 4 ml are slowly introduced into the urethra and the syringe is withdrawn, continuing to press the piston. In this case, the gel covers the entire length of the urethra.

    Before carrying out the manipulations, leave the drug in the urethra for 5-10 minutes to achieve a complete anesthetic and disinfecting effect.

    Children use a syringe with 6 ml of gel. The introduction of the drug in children is carried out as in adults - respectively, the sex of the child.

    In gynecology, a syringe with 6 ml or 11 ml of gel is used (depending on the risk of infection). To facilitate the introduction into the cervix and uterine cavity use the installation tip. Fill the entire length of the tube of the installation tip by pressing the syringe onto the piston. After treatment of the external genitalia, vagina and cervix with a disinfectant solution, the cervix is ​​exposed in the mirrors. The area of ​​the outer throat of the cervix is ​​covered with gel. The tip is advanced through the cervical canal into the uterine cavity pre-shedding the gel and slowly injected into the uterine cavity with 2-3 ml (5-6 ml) of the gel.Continuing to press the plunger of the syringe, the installation tip is removed from the cavity and cervix (the entire length of the cervical canal is covered with gel). Further manipulations are carried out 10 minutes after the introduction of the gel.

    Side effects:

    Allergic reactions (allergic dermatitis, skin rash, Quincke's edema), burning in the place of application.

    Overdose:

    Symptoms: In case of severe damage to the urethra, it is possible to develop side effects associated with the systemic action of lidocaine (bradycardia, convulsions, collapse); if the drug is used improperly, orthostatic hypertension of the central genesis is possible.

    Treatment: with bradycardia - beta-adrenostimulants (alupent), with convulsions - small doses of short-acting barbiturates or short-acting muscle relaxants (succinylcholine), in case of collapse - epinephrine or dopamine in / in.

    Interaction:

    Joint use with antiarrhythmic drugs may lead to an increase in the severity of side effects of lidocaine.

    Avoid joint use with iodine preparations.

    MAO inhibitors enhance the local anesthetic effect of lidocaine.

    Incompatible with soap, as well as detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethyl cellulose). Compatible with LC containing a cationic group (benzalkonium chloride).

    Special instructions:

    The drug is sterile and is intended for single administration.

    In the case of lactation, refrain from breastfeeding for 12 hours after use.

    Form release / dosage:gel for topical application
    Packaging:

    For 6 ml and 11 ml in disposable syringes, each syringe in a blister, 10 blisters in a cardboard box along with instructions for use.

    Storage conditions:

    List B. In a dark place inaccessible to children, at a temperature of no higher than 25 C.

    Shelf life:5 years. Do not use after expiry date.
    Terms of leave from pharmacies:On prescription
    Registration number:П N015801 / 01
    Date of registration:11.08.2009
    The owner of the registration certificate: Farco-Pharma GmbH Farco-Pharma GmbH Germany
    Manufacturer: & nbsp
    Information update date: & nbsp27.09.2015
    Illustrated instructions
      Instructions
      Up